Inside informationEnglish
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 30/01/2026, 13:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112146_20260130